Sean J Pittock Selected Research

Sean J Pittock Research Topics

Disease

74	Neuromyelitis Optica (Devic's Disease) 06/2024 - 12/2004
53	Neoplasms (Cancer) 04/2024 - 05/2003
41	Multiple Sclerosis 05/2024 - 12/2004
26	Optic Neuritis (Retrobulbar Neuritis) 05/2024 - 07/2005
22	Demyelinating Diseases (Demyelinating Disease) 12/2023 - 07/2007
21	Encephalitis (Encephalitis, Rasmussen) 04/2024 - 12/2014
20	Seizures (Absence Seizure) 06/2023 - 01/2003
18	Nervous System Diseases (Neurological Disorders) 01/2024 - 05/2003
14	Myelitis 01/2023 - 01/2006
13	Transverse Myelitis (Necrotizing Myelitis) 01/2023 - 01/2006
13	Glioma (Gliomas) 01/2022 - 05/2012
12	Brain Diseases (Brain Disorder) 06/2023 - 10/2008
12	Neurologic Manifestations (Neurological Manifestations) 10/2020 - 07/2005
11	Ataxia (Dyssynergia) 12/2021 - 09/2008
10	Autoimmune Diseases of the Nervous System 04/2024 - 11/2011
10	Spinal Cord Diseases 10/2021 - 03/2002
10	Inflammation (Inflammations) 01/2021 - 10/2008
9	Epilepsy (Aura) 02/2021 - 05/2012
6	Autoimmune Diseases (Autoimmune Disease) 05/2024 - 02/2012
6	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 06/2023 - 07/2005
6	Stiff-Person Syndrome (Stiff Man Syndrome) 01/2023 - 12/2009
6	Cognitive Dysfunction 01/2023 - 04/2010
6	Pain (Aches) 12/2022 - 09/2012
6	Myasthenia Gravis 01/2022 - 01/2009
6	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 10/2020 - 04/2008
6	Breast Neoplasms (Breast Cancer) 11/2019 - 07/2005
6	Cerebellar Ataxia (Dysmetria) 10/2018 - 10/2009
6	Dementia (Dementias) 01/2017 - 10/2008
5	Thymoma (Thymic Carcinoma) 01/2023 - 07/2014
5	Acute Disseminated Encephalomyelitis (Postinfectious Encephalomyelitis) 01/2023 - 08/2009
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2022 - 09/2006
5	Leukocytosis (Pleocytosis) 01/2022 - 10/2010
4	Optic Nerve Diseases (Optic Neuropathy) 05/2024 - 01/2012
4	Adenocarcinoma 01/2023 - 10/2009
4	Meningoencephalitis 01/2022 - 11/2016
4	Neuralgia (Stump Neuralgia) 12/2021 - 01/2018
4	Central Nervous System Diseases (CNS Diseases) 02/2021 - 02/2008
4	Polyneuropathies (Polyneuropathy) 01/2020 - 10/2002
4	Edema (Dropsy) 01/2020 - 10/2008
4	Myoclonus (Nocturnal Myoclonus) 01/2020 - 09/2007
4	Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome) 12/2017 - 05/2003
4	Teratoma (Teratoid Tumor) 01/2017 - 04/2010
3	COVID-19 06/2024 - 01/2022
3	Paraneoplastic Cerebellar Degeneration 01/2024 - 10/2011
3	Cerebellar Diseases (Cerebellar Syndrome) 01/2024 - 12/2021
3	Infections 12/2023 - 01/2021
3	Tremor (Tremors) 01/2023 - 10/2010
3	Muscular Diseases (Myopathy) 01/2022 - 08/2014
3	Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) 12/2021 - 01/2016
3	Polyradiculoneuropathy (Polyradiculoneuritis) 12/2021 - 01/2018
3	Respiratory Tract Infections (Respiratory Tract Infection) 05/2021 - 01/2003
3	Optic Atrophy 01/2018 - 10/2011
3	Small Cell Carcinoma 12/2017 - 03/2013

Drug/Important Bio-Agent (IBA)

121	Immunoglobulin G (IgG)IBA 06/2024 - 05/2003
87	AutoantibodiesIBA 03/2024 - 05/2003
52	AntibodiesIBA 06/2023 - 11/2004
38	Myelin-Oligodendrocyte GlycoproteinIBA 05/2024 - 01/2018
37	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2006
30	Proteins (Proteins, Gene)FDA Link 04/2024 - 07/2005
17	Aquaporin 4IBA 01/2023 - 07/2006
15	Complement System Proteins (Complement)IBA 05/2024 - 07/2007
15	Aquaporins (Water Channels)IBA 12/2022 - 08/2005
15	AntigensIBA 01/2022 - 11/2004
13	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2022 - 04/2010
13	Leucine (L-Leucine)FDA Link 01/2022 - 05/2012
12	Semaphorin-3AIBA 01/2022 - 07/2005
10	Cholinergic ReceptorsIBA 01/2022 - 09/2007
10	Voltage-Gated Potassium Channels (Voltage-Gated Potassium Channel)IBA 12/2020 - 09/2007
9	N-Methylaspartate (NMDA)IBA 06/2023 - 11/2011
9	Glutamate Decarboxylase (Decarboxylase, Glutamate)IBA 01/2022 - 09/2006
8	inebilizumabIBA 06/2024 - 10/2019
8	Adrenal Cortex Hormones (Corticosteroids)IBA 04/2024 - 08/2009
8	Intravenous Immunoglobulins (IVIG)FDA Link 04/2024 - 11/2012
8	eculizumab FDA Link 12/2023 - 06/2013
8	SteroidsIBA 12/2022 - 09/2010
8	amphiphysinIBA 10/2020 - 07/2005
7	Immunoglobulins (Immunoglobulin)IBA 11/2020 - 02/2008
6	Glial Fibrillary Acidic ProteinIBA 01/2023 - 11/2016
6	Oligoclonal BandsIBA 01/2023 - 01/2015
6	AutoantigensIBA 01/2022 - 07/2005
6	Calcium Channels (Calcium Channel)IBA 01/2020 - 10/2009
5	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2019
5	ANNA1 antibodyIBA 01/2023 - 02/2009
4	ravulizumabIBA 05/2024 - 01/2023
4	Retinaldehyde (Retinal)IBA 05/2024 - 01/2019
4	Peptides (Polypeptides)IBA 01/2024 - 08/2014
4	Glycine Receptors (Glycine Receptor)IBA 01/2023 - 01/2013
4	GadoliniumIBA 10/2021 - 07/2017
3	N 30IBA 01/2023 - 01/2017
3	Immunoglobulin M (IgM)IBA 12/2021 - 10/2008
3	EpitopesIBA 01/2020 - 01/2011
3	Glutamic Acid (Glutamate)FDA Link 01/2020 - 10/2008
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2016
3	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019 - 05/2012
3	Rituximab (Mabthera)FDA Link 03/2018 - 09/2015
3	Potassium Channels (Potassium Channel)IBA 01/2017 - 09/2012

Therapy/Procedure

46	Immunotherapy 04/2024 - 09/2006
27	Therapeutics 06/2024 - 05/2003
3	Plasma Exchange 01/2023 - 07/2011
3	Plasmapheresis 01/2021 - 08/2009